Caris Life Sciences (CAI) Change in Inventory (2024 - 2026)
Caris Life Sciences (CAI) posted quarterly Change in Inventory of $13.3 million for Q1 2026, up 746.68% year-over-year from $1.6 million in Q1 2025, and up 38.75% quarter-over-quarter from $9.6 million in Q4 2025.
Analysis
Caris Life Sciences (CAI) Change in Inventory (2024 - 2026) Analysis & Trends
Caris Life Sciences' Change in Inventory history runs 3 years deep, the most recent figure standing at $13.3 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 746.68% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $36.1 million (changed N/A YoY), while the FY2025 annual figure was $20.8 million, up 480.11% from the prior year.
- Change in Inventory for Q1 2026 stood at $13.3 million, up from $9.6 million in the prior quarter.
- The five-year high for Change in Inventory was $13.3 million in Q1 2026, with the low at -$2.1 million in Q1 2025.
- The 3-year median for Change in Inventory is $4.7 million (2025), against an average of $5.2 million.
- Peak annual rise in Change in Inventory reached 869.71% in 2025, while the deepest fall reached 158.82% in 2025.
- Caris Life Sciences' Change in Inventory stood at -$1.2 million in 2024, then soared by 869.71% to $9.6 million in 2025, then jumped by 38.75% to $13.3 million in 2026.
- Business Quant data shows CAI's Change in Inventory at $13.3 million in Q1 2026, $9.6 million in Q4 2025, and $8.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Caris Life Sciences | 7.08 Bn | 6.28 Bn | 182.38 Mn | 48.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.31 Mn |
| Mar 31, 2026 | 13.33 Mn |
| Dec 31, 2025 | 9.61 Mn |
| Sep 30, 2025 | 8.52 Mn |
| Jun 30, 2025 | 4.68 Mn |
| Mar 31, 2025 | -2.06 Mn |
| Dec 31, 2024 | -1.25 Mn |
| Sep 30, 2024 | 3.29 Mn |